Sofinnova Investments, Inc. Liquidia Corp Transaction History

Sofinnova Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$2.42 - $3.6 $357,540 - $531,878	-147,744 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$2.6 - $5.79 $1.38 Million - $3.08 Million	-531,656 Reduced 78.25%	147,744 $436,000
Q3 2020 Nov 13, 2020	SELL	$4.34 - $8.28 $523,404 - $998,567	-120,600 Reduced 15.08%	679,400 $3.34 Million
Q2 2020 Aug 13, 2020	BUY	$4.86 - $11.44 $3.89 Million - $9.15 Million	800,000 New	800,000 $6.74 Million

171

44.3M

1.55M

1.52M

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $710M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.